Back to results
US 6,656,684 B1Granted
Method for predicting tumor recurrence
AssigneeUniversity of Iowa Research Foundation
InventorAnthony D. Sandler
Life of this patent
Estimating the term…
Abstract
The present invention provides methods and kits for predicting recurrence of tumor or cancer in a mammal by calculating the ratio of the amount of Survivin and the amount of PAF in a physiological sample.
Claims14
A diagnostic method for predicting the recurrence of a tumor or cancer in a human comprising:
- (a) contacting RNA from a human physiological sample suspected of being tumorigenic or cancerous with a Survivin-specific oligonucleotide comprising a first label, and a pro-apoptosis factor (PAF)-specific oligonucleotide comprising a second label under conditions effective to hybridize the RNA to the oligonucleotides so as to yield a first population of RNA labeled with the Survivin-specific oligonucleotide and a second population of RNA labeled with the PAF-specific oligonucleotide;
- (b) quantifying the first and second populations of labeled RNA to determine an amount of Survivin RNA and an amount of PAF RNA present in the sample;
- and
- (c) calculating the ratio of the amount of Survivin RNA and the amount of PAF RNA;
- wherein a Survivin:PAF ratio of more than about 1.5 is predictive that the tumor will recur.
2 more elements
Dependencies are inferred from the claim text.